- Sold by Vantage Market Research
Free | 1 month subscription available.
Vantage Market Research forecasts a robust future for the Pharma 4.0 market, with revenue expected to surge from USD 14.05 billion in 2023 to USD 61 billion by 2032. This translates to a compelling CAGR of 17.80%. North America is currently leading the global Pharma 4.0 market, and this trend is anticipated to continue throughout the forecast period. This dominance can likely be attributed to the region's longstanding embrace of advanced technological solutions across various industries.